As we are on the brink of 2023, let's go down the memory lane to revisit all our remarkable memories and achievements of the year that have made Venus go closer to its Mission 2025. We started 2023 with a grand O&M meet on 7th January, setting forth the guidelines and roadmap to be followed in order to achieve excellence. As we’re approaching another O&M meet on 6th January 2024, we’ve successfully achieved all our expected targets and even surpassed a few. Here are some of the most notable and profound accomplishments of Venus in 2023.

Let’s start with the Awards & Accreditation we’ve received. Venus has been honoured with the FICCI Healthcare Awards 2023 Excellence in Patient Safety & Care (Category), Best Working Conditions 2022 Under Haryana State Safety, Health & Welfare Awards, and awarded the ‘Great Place To Work’ award for the second consecutive year. Along with this, we’ve obtained the CII Responsible Export Organization Certification for the Second Consecutive Year, the prestigious 'Three Star Export House' Certification from the Government of India, and the FSSAI license for canteen food services and R3SET products.

For the past 20 years, Venus has been at the forefront, actively working in the Fight Against AMR. Our continuous efforts in the research and development of new antibiotics and drugs have positioned us as one of the leading brands in India working to combat AMR. In 2023, Venus became a part of IAIH – India AMR Innovation Hub as another step to enhance our determination towards the fight against this global health threat by working with national and international stakeholders. Furthermore, Venus and Cipla, two leading pharmaceutical companies, have collaborated to develop and market Ceftriaxone Sulbactum EDTA all across the country, marking another significant milestone in the fight against AMR.

2023 also brought global excellence for Venus. We have attained more than 20 GMP certifications, receiving from Ukraine, Kenya, and Saudi Arabia this year. In addition, we’ve also achieved Market Authorisations from the Philippines, Uzbekistan, Paraguay, Palestine, Georgia, Moldova, etc., in 2023, bringing us to a total of 800+ MAs.

Apart from being a global prodigy, Venus also focuses on its internal growth by focusing on continually enhancing employees’ skills through comprehensive training and development programs. These initiatives include training from in-house & external trainers, such as the Disaster & Hazardous Waste Management Program by Jyoti Baweja, Supply chain management training, etc.

Another prominent undertaking in 2023 was certifying all employees according to NSDC regulations, catering to their vocational training and certification for skill development. We’ve already covered 23 departments so far and efforts are ongoing to ensure that all employees receive the required upgrades.

Venus is also dedicated towards employee well-being, evident through its collaboration with multiple doctors in Tricity. This collaboration ensures that all these doctors are readily available for our employees’ healthcare requirements. Additionally, we regularly hold health check-up camps, like Bone Mineral Density check camp, Blood Donation camp, etc., for regular evaluation and health engagement.

2023 was also a year of advancing medical education through various CME programs by Venus. These programs, held at institutions like Lucknow Medical College and Punjab Institute of Medical Sciences, focused on addressing key healthcare challenges and providing healthcare professionals with valuable insights into the latest advancements in medical science. We also conducted a CME activity at CK Birla Hospital in Jaipur and other tertiary care hospitals, promoting hand hygiene in healthcare settings.

Talking about activities and events, Venus has always been enthusiastic about celebrating the rich Indian culture through vibrant celebrations. From joyous Lohri and Diwali festivities to jubilant Garba event and the spiritual fervour of Teej and Janmashtmi, we embraced the diverse traditions of our country beautifully. Furthermore, Venus dedicatedly celebrated Teachers Day to honour the contributions of educators, spread the Christmas cheer, and promoted holistic well-being on International Yoga Day.

Being a leading pharmaceutical company, Venus has showcased its commitment to cutting-edge research and global networking at major international pharmaceutical events as well. Venus Remedies Limited and Venus Pharma GmbH actively participated in the CPhl Barcelona 2023 and ECCMID. These events, attended by over 100,000 pharmaceutical professionals annually, offer networking and business opportunities for global market expansion, contributing to industry growth and innovation. We’ve also launched our flagship R&D product ‘Elores’ in Oman and Ecuador and relaunched R3SET products, setting new standards in the antibiotic segment and showcasing our unwavering dedication to innovative healthcare solutions.

Owing to its commitment to corporate social responsibility or CSR, Venus has embarked on various inspirational initiatives throughout 2023. From launching the "IndiaSterlocked" campaign that aims to spread awareness about health and hygiene to the Venus Army initiatives that empower our employees to make a positive difference in their communities, we’ve demonstrated our CSR spirit. Furthermore, our efforts towards environment and sustainability are highlighted through the successful plantation of 52,000 trees through the Cauvery Calling initiative.

Additionally, our focus on education is reflected in initiatives like the implementation of the Education Grant-In-Aid policy and the recent adoption of the Government Senior Secondary School Sector-19 Panchkula for its upliftment. These initiatives underscore the holistic approach of Venus to CSR and our commitment to making a meaningful impact on society.

We also have a unique ‘Venus Asks’ endeavour, where we interview and engage our valuable employees in a one-on-one conversation. This, too, was a huge success this year, with over 50+ sessions. Alongside, 2023 will also be marked as the birth year of our esteemed Corporate video, a compilation of what Venus is about, what we stand for and our remarkable journey.

To wrap it all up, 2023 has been a wonderful journey for Venus, marked by a multitude of cherished memories and successful initiatives. It was a testament to our steadfast commitment to innovation and excellence in the pharmaceutical industry. As we step into 2024, we take pride in what we accomplished so far and eagerly await the opportunities that lie ahead. Here's to another year of growth, innovation, and making a positive impact on the world around us.